Justin Anslow is an associate in the Corporate Practice Group in the firm's New York office.

Areas of Practice

Justin advises public and private companies in securities offerings, corporate governance and SEC reporting. He represents issuers as well as investors, underwriters and placement agents in connection with both public and private offerings of equity and debt securities. Justin also assists clients with business entity formation matters and general corporate law matters.



Recent Selected Transactions

Represented LunaPBC, Inc., the founder and manager of the first community-owned health and DNA research platform, in a first-of-its-kind Tier 2 Regulation A offering

Represented LKQ Corporation (NASDAQ: LKQ) and its subsidiary, LKQ European Holdings B.V., in a private offering of €1 billion of senior notes 

Represented LendingTree, Inc. (NASDAQ: TREE) in its private offering of $300 million of convertible senior notes 

Represented Hennessy Capital Acquisition Corp. II (NASDAQ: DSKE) in its $200 million initial public offering

Represented BioXcel Therapeutics, Inc. (NASDAQ: BTAI) in its $60 million initial public offering

Represented Synergy Pharmaceuticals (NASDAQ: SGYP) in its $56 million public offering of common stock and warrants

Represented Global Partner Acquisition Corp. (NASDAQ: GPAC)  in its $155 million initial public offering

Represented placement agent in $37.5 million (Series A) private placement financing for X4 Pharmaceuticals


Media Mentions


J.D., The George Washington University Law School, 2014

B.B.A., University of Wisconsin, 2011, with distinction


  • New York
Jump to Page

By scrolling this page, clicking a link or continuing to browse our website, you consent to our use of cookies as described in our Cookie and Advertising Policy. If you do not wish to accept cookies from our website, or would like to stop cookies being stored on your device in the future, you can find out more and adjust your preferences here.